Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot-Assisted microsurgery trial aims to improve access and outcomes

NCT ID NCT06725030

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This study is testing the Symani Surgical System, a robotic device designed to help surgeons perform very delicate microsurgeries. The trial will include 455 adults undergoing free tissue transfer or lymphedema surgery. Researchers will check how well the robot works for reconnecting tiny blood vessels and whether it causes any device-related problems within 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Symani Surgical System (a robotic device for microsurgery)
What this could lead to
If successful, this could make complex microsurgeries more accessible and improve outcomes for conditions like lymphedema.
What could go wrong
This is a post-market study, so the device is already approved. However, it is observational and may not prove broad effectiveness or safety beyond the specific procedures studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 455 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The patients selected for the PRECISE Study will be adults with a clinical indication for a microsurgical anastomosis of vessels between 0.1 and 2.5 mm in conjunction with open free flap surgery of the breast or extremities and/or lymphovenous anastomosis surgery of the extremities.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Pre Operative Inclusion Criteria: 1. At least 22 years of age 2. Patient agrees to participate in the study, return for all required follow-up visits, complete all study procedures, and has willingly provided written informed consent after receiving all information related to the study, its requirements, and the robotic assisted procedure 3. Patient has a clinical indication for a microsurgical anastomosis of vessels between 0.1 and 2.5 mm in conjunction with open free-flap surgery of the breast or extremities and/or lymphovenous anastomosis surgery of the extremities 4. Investigator deems the candidate acceptable for free flap transfer surgery and/or lymphovenous anastomosis surgery with a robotic assisted microsurgical anastomosis in accordance with the Symani System's Instructions for Use (IFU) Cohort Specific Pre- Operative Inclusion Criteria: Free Tissue Transfer Surgery: N/A Lymphovenous Anastomosis Surgery 1. Swelling of one limb that is not completely reversed by elevation or compression 2. Stage I-II lymphedema at screening, based on the International Society of Lymphology (ISL) staging system 3. At least one of the following positive quantitative measurements: 1. Volumetry differential between affected limb and contralateral limb must be at least 10% of the other 2. Bioimpedance (L-Dex) differential, if feasible, between affected limb and contralateral limb of at least 10 units 4. Completion of a full course of complete decongestive therapy (CDT), according to ISL guidelines, for at least 12 weeks prior to screening, including use of compression garments for at least 12 weeks without change in regimen 5. Willingness to comply with recommended regimen of self-care, with consistent use of appropriately sized compression garments from screening through the entire study duration (through the 3-month follow-up visit). Pre-Operative Exclusion Criteria: 1. Patients who are incapable and/or unwilling to provide informed consent 2. Active systemic infection under treatment with intravenous antibiotics 3. Clinically significant cardiovascular, digestive, respiratory, endocrine, or central nervous system disorders, previous mental disorders, or other disorders that may significantly affect the data collection or the ability to comply with the protocol per the investigators discretion 4. Known history of significant bleeding, coagulopathy, or Von Willebrand's disease 5. Patients with implanted pacemaker 6. Planned vein graft 7. Currently receiving chemotherapy or radiation therapy 8. History of chronic kidney disease 9. History of chronic liver disease 10. Currently enrolled in any other investigational clinical studies that the investigator believes may impact patient safety or outcomes 11. Patients belonging to vulnerable populations, such as pregnant women, or ineligible to participate for other reasons in the judgement of the investigator Cohort Specific Pre-Operative Exclusion Criteria: Free Tissue Transplant Surgery: 1. Patients with buried flaps 2. Multiple flaps planned for the procedure Lymphovenous Anastomosis Surgery: 1. Patients \> 75 years of age 2. Patients with prior lymphatic reconstruction surgery 3. Patients with venous edema (arising from increased capillary filtration) 4. Patients with other medical conditions that could lead to acute limb edema, such as (but not limited to) acute venous thrombosis or heart failure 5. Patients with other medical conditions that could result in symptoms which overlap symptoms of lymphedema 6. Current infection in the affected limb 7. Patients who experience more than one episode of cellulitis in a six month period over the past two years 8. Current evidence or a history of malignancy within the past 6 months (if the participant has undergone cancer treatment, this must have been completed \> 6 months prior to enrollment) 9. Known iodine sensitivity 10. Patient's lymphatic disease is due to lipedema 11. Patients with bilateral lymphedema or lymphedema in multiple anatomical locations Intra Operative Exclusion Criteria: 1. Any presenting condition discovered intraoperatively that, in the opinion of the investigator, would make participating in this study not in the patient's best interest 2. The patient does not have at least one robotic stitch attempted during the index procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anastomosis, surgical are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    6 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cedars Sinai Medical Center

    RECRUITING

    Beverly Hills, California, 90048, United States

  • Cleveland Clinic

    RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Email: •••••@•••••

  • Erie County Medical Center

    RECRUITING

    Buffalo, New York, 14215, United States

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Tampa General Hospital

    RECRUITING

    Tampa, Florida, 33606, United States

  • Yale New Haven Hospital

    RECRUITING

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.